Summers Value Partners: "Our Price Target on UTMD is $120 per Share"
Summers Value Partners, an investment management firm, published its “Summers Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Utah Medical Products Inc (UTMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 230,614 | $15,430,383 | +2% | 0.02% |
| 2. | Minerva Advisors Minerva Advisors | 42,328 | $2,817,775 | +462% | 1.63% |
| 3. | Millennium Management Israel Englander | 25,112 | $1,680,244 | -36% | 0% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 23,800 | $1,592,458 | +7% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 16,921 | $1,132,184 | -19% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.76 | 2,000 | Officer, Director | 290,241 | 2011-08-11 | Filing | |
| $27.10 | 250 | Officer, Director | 288,241 | 2011-06-06 | Filing | |
| $28.00 | 1,000 | Director | 1,400 | 2010-12-10 | Filing | |
| $25.51 | 1,800 | Officer, Director | 275,991 | 2010-08-23 | Filing | |
| $21.85 | 200 | Director | 400 | 2009-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $93.47 | 700 | Director | 21,461 | 2023-05-18 | Filing | |
| $90.81 | 449 | Director | 22,311 | 2022-11-18 | Filing | |
| $90.00 | 161 | Director | 22,760 | 2022-11-17 | Filing | |
| $92.50 | 40 | Director | 22,921 | 2022-11-11 | Filing | |
| $85.20 | 2,000 | Director | 5,338 | 2022-05-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 389,708 | $32,821,208 | 0% | |
| 2. | 204,421 | $17,216,336 | 0% | |
| 3. | 170,739 | $14,379,639 | 0% | |
| 4. | 163,044 | $13,732,105 | 0% | |
| 5. | 105,011 | $8,844,026 | 0.51% |
News See All
Summers Value Partners on Utah Medical (UTMD): "We Believe the Company’s Business is Poised to Rebound"
Summers Value Partners, an investment management firm, published its "Summers Value Fund" second quarter 2021 investor letter – a copy of which can be downloaded here.
Is Utah Medical Products, Inc. (UTMD) A Good Stock To Buy?
In this article we are going to use hedge fund sentiment as a tool and determine whether Utah Medical Products, Inc. (NASDAQ:UTMD) is a good investment right now.
Is UTMD A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Utah Medical Products, Inc. (UTMD): Hedge Funds Cautiously Watching
In this article you are going to find out whether hedge funds think Utah Medical Products, Inc. (NASDAQ:UTMD) is a good investment right now.
Here is What Hedge Funds Think About Utah Medical Products, Inc. (UTMD)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Are Dumping Utah Medical Products, Inc. (UTMD)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Hedge Funds Aren't Crazy About Utah Medical Products, Inc. (UTMD) Anymore
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Johnson & Johnson (JNJ), Novartis AG (ADR) (NVS): The Cooper Companies, Inc. (COO) Leveraging Share Gains for Eye-Opening Growth
The Cooper Companies, Inc. (NYSE:COO), or more formally "The Cooper Companies" is a sort of odd duck in the med-tech world.
Billionaire Hedge Funds
